07:00 , Sep 28, 2009 |  BioCentury  |  Finance

Ebb & Flow

The pair of life sciences companies on IPO road shows may give investors and other companies clues on the opening of an IPO window. Profitable plasma-derived protein company Talecris Biotherapeutics Inc. may price this week,...
07:00 , Jul 13, 1998 |  BioCentury  |  Finance

Amylin's timing is tough

As Amylin (AMLN) markets its 3 million share registered direct offering, the company will face the hurdle of persuading investors to pony up cash just before the company unveils pivotal data. AMLN hopes to present...